Felix Issue 0953, 1993
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Edp Vilar De Mouros Divulga Horários De Nota De Imprensa Concertos
EDP VILAR DE MOUROS DIVULGA HORÁRIOS DE NOTA DE IMPRENSA CONCERTOS • Festival pronto para receber as 18 bandas confirmadas • Magia do EDP Vilar de Mouros acontece nos dias 22, 23 e 24 e traz muitas novidades • The Cult, Manic Street Preachers, The Offspring, Skunk Anansie, Prophets of Rage, e Gogol Bordello são algumas das bandas que vão atuar no palco EDP, enquanto artistas como os Therapy?, The Sisters of Mercy, Tape Junk, The House of Love atuam no palco MEO. A organização do festival EDP Vilar de Mouros acaba de divulgar os horários dos concertos IPSIS que vão decorrer nos dois palcos, o EDP e o MEO, preparados para receber as 18 bandas que Catarina Teixeira Soraia Tomaz atuam nos dias 22, 23 e 24 de agosto, sob a promessa de um ano inesquecível para todos os edpvilardemouros @ipsis.pt apaixonados por música. Tlf: +351 211 978 073 Tlm: +351 93 285 A edição 2019 traz-nos um cartaz eclético e com confirmações de peso: no palco EDP atuam 77 74/ +351 910 157 923 bandas como os The Cult, Manic Street Preachers, Anna Calvi, The Offspring, Skunk Anansie, Nitzer Ebb, Prophets of Rage, Gogol Bordello e Linda Martini, e, no palco MEO os Therapy?, The Wedding Present, Tape Junk, The Sisters of Mercy, The House of Love, Clan of Xymox, Fisher-Z, Gang of Four e Jarojupe. Horários dos concertos Deslocação (Desconto CP e Transfer Gratuito Óptica Pistosga) Os festivaleiros com passe do evento têm 30% de desconto na CP na compra de viagens em intercidade, inter-regionais e regionais com destino e partida de Caminha, de 18 a 25 de agosto. -
Issue 180 • 19 July 2007
reporter www.imperial.ac.uk Issue 180 • 19 July 2007 Centenary Queen bestows new charter for Imperial’s birthday celebrations > centre pages health minister staff party rocks Professor Sir Ara Darzi south kensington appointed to the Roving reporters government capture the day PAGE 3 PAGES 8–9 in brief AHSC news New Paediatric Research Unit declared open The Paediatric Research Unit, the UK’s first unit solely devoted to paediatric clinical research, • Have your say people to ask questions Kensington Town Hall on 10 was officially opened on 9 July. The Unit is run by The twelve-week consulta- and to express their views. July. Delegates considered researchers from Imperial and St Mary’s Hospital, tion on the proposal to A further 80 people packed how to achieve the mission and is based next to the hospital’s paediatric wards create an Academic Health into the joint overview and and goals of the AHSC. in Paddington. Professor John Warner, Chair in Science Centre (AHSC) scrutiny committee meeting Paediatrics, Head of the Department of Paedi- atrics at Imperial and consultant paediatrician will close on 31 July. The at Portcullis House. • AHSC appointments at St Mary’s Hospital, spoke at the opening. He response so far has been The Joint Steering Group explained that researchers should be designing positive, with approximately • Intranet update has agreed that senior posts therapies specifically for children and their 70 per cent of the comments Staff meetings have now in the AHSC will be for the problems, rather than scaling down treatments received supportive of the been held across the integrated organisation that were created for adults. -
Data Protection Learnings from Across the Pond
Data Protection Learnings from Across the Pond From GDPR to LGPD Okan Kibaroglu, Head of Governance GDPR to LGPD 26/08/2019 Agenda • Your presenter • This is Imperial! • Principles to keep in mind • Our experience, a detailed synopsis; based on “principles” • Lessons Learnt About me About me – Okan Kibaroglu • Born in Turkey in 1966 • BSc and MSc in Computer Science from Bogazici University, Istanbul • Worked at different industries and management levels in IT since 1994 • At Imperial College for 14 years, and Head of Governance for 5 years • Married with three grown up children This is Imperial! 26/08/2019 Imperial College: Our Mission Imperial College London’s mission is to achieve enduring excellence in research and education in science, engineering, medicine and business for the benefit of society. This is Imperial 26/08/2019 Our standing • Times Higher Education World University Rankings 2019: 9th overall, 3rd in UK • Times Higher Education World’s Most International Universities 2019: 9th in the world • QS World University Rankings 2019: 8th in the world • Research Excellence Framework (REF): 1st for high impact research of any UK university • Reuters Europe’s Most innovative universities 2019: 1st in UK, 3rd in Europe • The Guardian University Guide 2019: 1st for Career Prospects This is Imperial! 26/08/2019 History 1851–1890: Building on the Great Exhibition, Prince Albert supported the idea of South Kensington becoming the London Centre for Science and Arts. Constituent Colleges formed. 1907: Imperial College founded by merger of: • City and Guilds College • Royal College of Science • Royal School of Mines 1987: Management School formed (now Imperial College Business School) This is Imperial! North 26/08/2019 West London Imperial Today Hospitals Nine campuses: • South Kensington • White City • Silwood Park • 6x Hospitals Silwood – Charing Cross Park – Chelsea & Westminster – Hammersmith – North West London Hospitals Campus – Royal Brompton – St Mary’s This is Imperial White City – a new era of discovery for Imperial, London and the wider world. -
RBH-CHD Network Annual Report.Pdf
The Royal Brompton & Harefield Hospital NHS Foundation Trust Royal Brompton Hospital Congenital Heart Disease Network 2018/19 Annual Report Authors: Dr Nitha Naqvi Dr Leonie Wong Lawrence Mack Simon Boote Approved by: Congenital Heart Disease Working Group Ratification Committee: Congenital Heart Disease Network Board Date Ratified: 29/04/2019 Chairman: Dr Angela Tillett Implemented by: For reference only Issue Date: April 2019 Version: 001 Review Date: March 2020 Review interval: 12 Months Issued: April 2019 Version: 001 Page | 1 Link - Contents 1 Contents Page 1 Contents Page .......................................................................................................................................... 2 2 A message from our Clinical Director ................................................................................................... 4 3 RBH-CHD Network Strategic Vision Statement .................................................................................. 5 4 Summary of Achievements Against our Work Plan – 2018/19 ......................................................... 5 5 Research ................................................................................................................................................... 6 5.1 Grants Awarded ................................................................................................................................ 7 5.2 Research Programmes Peer Reviewed Publications ................................................................. 7 5.3 Research Strategy -
Royal Brompton Hospital Nhs Trust
ROYAL BROMPTON & HAREFIELD NHS FOUNDATION TRUST LOCUM CONSULTANT IN CYSTIC FIBROSIS Applications are invited for the post of Locum Consultant in Cystic Fibrosis six month fixed term contract. The Royal Brompton & Harefield NHS Foundation Trust is seeking to appoint a LOCUM CONSULTANT IN CYSTIC FIBROSIS to be based at the Royal Brompton Hospital. The Trust is a world famous organisation with a proud history in the investigation, treatment and research of lung and heart disease. We are particularly proud of our ability to provide comprehensive specialist care for patients of all ages and their families. The post will be based at The Royal Brompton Hospital and the successful candidate will work closely with the current physicians in the Cystic Fibrosis Unit to lead the cystic fibrosis service, which attracts tertiary referrals from all over the UK. Applicants are required to be fully registered Medical Practitioners and must be on the GMC’s Specialist Register or be eligible for admission to the Register within three months from date of interview for the post. Informal enquiries may be made to Dr Nicholas Simmonds, Consultant in Respiratory Medicine on 0207 351 8997. For an application form and job description, please contact our Medical Recruitment Manager by email on [email protected] or 0207 351 8688 quoting reference number 312-LC-CF-0915 and we will organise for an application pack to be sent out to you. Alternatively, applications can be made via the NHS jobs website www.jobs.nhs.uk We regret that we are unable to contact applicants who are not selected for an interview, therefore if you do not hear from us within three weeks after the closing date, please assume you have not been successful on this occasion. -
MILLER's RIVER ROCKS on .2. • 4 Ammo Orelv111111
JUNE 4, 1993 ISSUE #328 fax: (609) 654-68.0 TOP PRIORITY STEVE "ILLER WIDE RIVER HARD ACTS TO FOLLOW IE DEVLINS I KNEW THAT ALTERNATIVE PICK HEY ZEUS! INSIDE: HARD HITTER • A RARE, LONG FORM CONVERSATION WITH ONE OF ROCK'S MCST CNIGMATIC AND IDIOSYNCRATIC HITMEN • dfARK AND BRIAN NOW SET TO SIMULCAST MORNING DRIVE AT {GON/PORTLAND. AND B-97(KKBB) BAKERSFIELD • 2D KELLY TO TEAM UP WITH KEN CAL VERT FOR WLLZ MORNINGS • 'RQR MAKES STEVEN SEAWEIT THEIR PERMANENT MORNING MAN JOHNNY YOUNG BACK TO NI3HTS, MARY HOLLOWAY TO MIDDAYS • _RS PROMOTES KAREN LEE TO NATIONAL DIR. PROMO 'EAST • VRCQ, FAYETTEVILLE LMA's WITH WZNS /DILLON SOUTH CAROLINA ire ▪ ..ISA RIEGEL ROUNDS UP A VIGILANTES OF LOVE INTERVIEW Ftyrrynnt • •vrvre I SAW YOUR MOMMY MILLER'S RIVER ROCKS ON .2._ • 4 ammo orelV111111 S T E V E M I L L E R BAN D W I D E R I V E R The first track from the long-awaited new studio recording. T H E U N MIS T A K A B LE S O U N D O F S U M M E R, '93- O n tour with Paul Rodgers JI .NE JULY AUGUST 4/ I M .,,poli. MN Target I:reeler Thu 7/1 unlasde. NS ji111,1 Ileac le Theater Sun 8/1 :mg» 11en•se. t. Parr. %se phighenier Sat fen %Maned.... NI %hereon 1emehiritealer Fri 7/2 e atone. Nt J Itenelt Thenier Mon 8/2 :ones. Menu. ti tes rhigeenter Sun 4/6 leirseute. -
What Do Imperial Medicine* Postgraduates Do?
What do Imperial Medicine* postgraduates do? Graph 1 – Destinations of 2016 graduates Percentage Entered Employment 66% Entered Further Study/Training 30% Seeking Employment 2% Not Available for Employment/Study/Training 2% Graph 2 – Comparison with previous years 2014 2015 2016 Entered Employment 56% 71% 66% Entered Further Study/Training 32% 23% 30% Seeking Employment 5% 3% 2% Not Available for Employment/Study/Training 7% 3% 2% Graph 3 – Sector of employment entered 2014 2015 2016 Agriculture 0.0% 0.6% 0.0% Oil/Mining 0.0% 0.0% 0.0% Manufacture 2.5% 4.1% 3.8% Utilities & Transport 0.0% 0.0% 0.0% Technical Consultancy/R&D 5.8% 2.4% 3.2% IT & Telecommunications 1.7% 2.9% 0.6% Banking/Financial 1.7% 0.0% 1.3% Accountancy 1.7% 0.6% 0.6% Business & Management Consultancy 1.7% 1.8% 0.6% Other Business Activities 5.0% 4.1% 6.4% Public Administration/Defence 1.7% 5.3% 6.4% Education 38.3% 23.5% 23.7% Health/Social Work 36.7% 52.9% 50.0% Others 3.3% 1.8% 3.2% *This data incorporates the Departments of Medicine; the Institute of Clinical Science; Public Health; Surgery & Cancer; and the National Heart and Lung Institute Careers Service www.imperial.ac.uk/careers Postgraduate Taught Courses Examples of employers and occupations for Medicine et al taught postgraduates who entered employment Examples of Employers Examples of Occupations • Academy of Education Development • Academic Clinical Fellow in General Practise • Aintree Hospital • Account Executive • Assemblies of God church • Associate Project Manager • Associate • Associate Scientist • -
VIVOTM Non-Invasive Time Assessment Protocol
TM VIVO non-invasive Time Assessment Protocol Short Study Title/Acronym: VIVOTM mapping Protocol REC Reference: Insert REC Reference IRAS Reference: 257755 CHIEF INVESTIGATOR: Dr Sabine Ernst, Consultant Cardiologist and Reader in Cardiology, Lead for Electrophysiology Research for the Royal Brompton Hospital Royal Brompton Hospital (RBH) Sydney Street London SW3 6NP Phone: 00442073518612 Email: [email protected] Fax: 00442073518131 SPONSOR REPRESENTATIVE: Mr Patrik Pettersson Royal Brompton and Harefield NHS Foundation Trust (RB&HFT) Royal Brompton Hospital (RBH) Research Office Chelsea Wing, Level 2 Sydney Street London SW3 6NP Phone: 0207 352 8121 ext. 8736 Email: [email protected] Fax: 0207 351 8829 VIVOTM mapping protocol VIVO-RBH01 Revision A – 15th January 2019 Page 1 of 38 Information in this protocol is confidential and should not be disclosed, other than to those directly involved in the execution or the ethical review of the study, without written authorisation from RB&HFT Research Office. Signature Page The Chief Investigator (CI) and the Research Office have discussed and agreed this study protocol. The investigators agree to perform the investigations outlined in this study protocol and to abide by this protocol except in the case of medical emergency that will be notified to the Research Office. The Investigator agrees to conduct the study in compliance with the study protocol and/or any subsequent amendments approved by the Sponsor and HRA, the Data Protection Act (1998), the Trust Information Governance Policy (or other local equivalent as applicable), the Research Governance Framework for Health & Social Care, 2nd Edition (2005), the Sponsor’s SOPs, and any other applicable regulatory requirements. -
Environmental Statement (Volume 1)
Imperial College Consort Reactor Decommissioning Environmental Statement (Volume 1) 121019 December 2014 Consort Reactor Decommissioning Environmental Statement RSK GENERAL NOTES Project No: 121019-01 (00) Title: Consort Reactor Decommissioning Environmental Statement (Volume 1) Client: Imperial College Date: 8th December 2014 Office: Hemel Hempstead Status: Draft Author: Rebecca Cail Technical reviewer: Peter Whipp Signature: Signature: Date: Date: Project manager: Clare Taylor Quality reviewer: Peter Whipp Signature: Signature: Date: Date: RSK Environment (RSK) has prepared this report for the sole use of the client, showing reasonable skill and care, for the intended purposes as stated in the agreement under which this work was completed. The report may not be relied upon by any other party without the express agreement of the client and RSK. No other warranty, expressed or implied, is made as to the professional advice included in this report. Where any data supplied by the client or from other sources have been used, it has been assumed that the information is correct. No responsibility can be accepted by RSK for inaccuracies in the data supplied by any other party. The conclusions and recommendations in this report are based on the assumption that all relevant information has been supplied by those bodies from whom it was requested. No part of this report may be copied or duplicated without the express permission of RSK and the party for whom it was prepared. Where field investigations have been carried out, these have been restricted to a level of detail required to achieve the stated objectives of the work. This work has been undertaken in accordance with the quality management system of RSK Environment. -
Clinical Senior Lecturer JD.Pdf
About Imperial College London Overview Imperial College London is one of the world’s greatest universities, renowned for its ground- breaking research, talented community of staff, students and alumni and its international reach. With a mission to achieve enduring excellence in research and education in science, engineering, medicine and business for the benefit of society, the College was founded in 1907 in South Kensington, bringing together nineteenth century institutions including the Royal College of Science, Royal School of Mines and City and Guilds College. Today Imperial collaborates extensively with neighbouring institutions, including the Royal College of Art and the Royal College of Music. From its location in this great cultural quarter, Imperial provides one of the world’s best educations in STEM subjects for more than 18,400 students, over half of whom come from overseas, reflecting its status as the UK’s most international university. Imperial has three academic faculties – Engineering, Medicine, and Natural Sciences – and the Imperial College Business School, as well as a significant number of interdisciplinary research centres focusing on challenging world problems. The College’s mission is supported by over 8,000 diverse staff, who collaborate in the UK and internationally, often across disciplines. In 2017-2018 the College had a total turnover of over £1 billion, of which £364.2 million directly supported research through grants and contracts. The College’s 2015-2020 Strategy is built on the foundations that make Imperial a strong academic institution and the talented and inspirational people who make up its community. The College’s success is recognised all over the world, as is evidenced by daily coverage of Imperial discoveries and innovations in the international media and claims many distinguished members, including 14 Nobel laureates, three Fields Medallists, and members of the Royal Society and National Academies. -
LAND at SILWOOD PARK Buckhurst Road, Ascot, Berkshire, SL5 7QN
Outline for indicative purposes only. LAND AT SILWOOD PARK Buckhurst Road, Ascot, Berkshire, SL5 7QN A PRIME DEVELOPMENT & INVESTMENT OPPORTUNITY FREEHOLD FOR SALE Silwood Park Buckhurst Road, Ascot, Berkshire, SL5 7QN 2 EXECUTIVE SUMMARY Savills are pleased to present a prime development & investment opportunity at Silwood Park. The Lots for sale are currently part of land owned by Imperial College London as investment properties, located adjacent to Imperial’s global centre for research and teaching in ecology, evolution, and conservation. • Prime M25 / M40 commuter belt Berkshire location – easy access to London and Heathrow Airport; • A rare opportunity to acquire iconic Grade II Listed Buildings and an income producing research park with a passing rent of circa £614,235 per annum; • Existing buildings extend to approximately 130,420 sq. ft. (12,116 sq. m) in part D1 (Education), C3 (Residential) and B1(b) (Research and Development) use; • Draft Allocation in the Royal Borough of Windsor and Maidenhead ‘Local Plan 2013 -2033: LOT A Submission version’ for 75 residential dwellings; • Positive pre-application to convert Silwood Manor House into 17 x dwellings with new build in the grounds; • Suitable for alternative uses including residential, retirement, office and hotel with conversion and/ or redevelopment potential (subject to necessary planning consents); • Approximate 12.2 hectare (30.1 acre) land holdings; • Picturesque setting within mature grounds; • Unconditional offers strongly preferred; Subject to Planning offers may be considered for the freehold interest; • The site will be sold subject to existing tenancies. LOT B LOT C Silwood Park Buckhurst Road, Ascot, Berkshire, SL5 7QN 3 THE OPPORTUNITY Silwood Park is owned and occupied by Imperial College London (ICL). -
Efficacy and Safety of TOBI Podhaler in Pseudomonas Aeruginosa-Infected Bronchiectasis Patients: Ibest Study
ORIGINAL ARTICLE BRONCHIECTASIS Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study Michael R. Loebinger1,2, Eva Polverino3, James D. Chalmers4, Harm A.W.M. Tiddens5,6, Herman Goossens7, Michael Tunney8, Felix C. Ringshausen 9, Adam T. Hill10, Rashidkhan Pathan11, Gerhild Angyalosi12, Francesco Blasi 13,14, Stuart J. Elborn2,15,16 and Charles S. Haworth17,18 on behalf of the iBEST-1 Trial Team Affiliations: 1Host Defence Unit, Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK. 2Imperial College London, London, UK. 3Respiratory Disease Department, Vall d’ Hebron University Hospital – VHIR, Barcelona, Spain. 4Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK. 5Dept of Paediatric Pulmonology and Allergology, Erasmus Medical Centre Sophia Children’s Hospital, Rotterdam, The Netherlands. 6Dept of Radiology and Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands. 7Dept of Clinical Microbiology, University Hospital Antwerp, Antwerp, Belgium. 8Halo Research Group, School of Pharmacy, Queen’s University Belfast, Belfast, UK. 9Dept of Respiratory Medicine, Hannover Medical School, and Biomedical Research in End-stage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany. 10Dept of Respiratory Medicine, Royal Infirmary of Edinburgh, and University of Edinburgh, Edinburgh, UK. 11Novartis Healthcare Private Limited, Hyderabad, India. 12Novartis Pharma AG, Basel, Switzerland. 13Internal Medicine Dept, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy. 14Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy. 15Halo Research Group, Centre for Experimental Medicine, Queen’s University Belfast, Belfast, UK. 16Imperial College and Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK.